Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ ImmunoCAP™ Tree Pollen Allergens

Catalog No. 14422601P
Click to view available options
Quantity:
10 Tests
16 Tests
Code:
Rt201
Rt205
Rt206
Rt207
Rt209
Rt211
Rt213
Rt214
Rt217
Rt218
Rt37
Rt41
Rt44
Rt45
Rt55
Rt56
Rt57
Rt71
t1
t10
t11
t12
t14
t15
t16
t17
t18
t19
t2
t20
t208
t21
t210
t212
t22
t222
t23
t3
t4
t5
t6
t7
t70
t72
t73
t8
t9
Common Name:
Acacia
American Beech
Australian Pine
Bald Cypress
Bayberry
Box Elder
Cedar
Cedar Elm
Chestnut
Common Silver Birch
Cottonwood
Cypress
Date
Douglas Fir
Elder
Elm
Eucalyptus, Gum-tree
Grey Alder
Hackberry
Hazel
Horn Beam
Italian/Mediterranean/Funeral Cypress
Japanese Cedar
Linden
Maple Leaf Sycamore, London Plane
Melaleuca, Cajeput-tree
Mesquite
Mountain Juniper
Mulberry
Oak
Olive
Pecan, Hickory
Peppertree
Pine
Privet
Queen Palm
Red Cedar
Red Mulberry
Scotch Broom
Spruce
Sweet Gum
Virgina Live Oak
Walnut
White Ash
White Hickory
White Pine
Willow
This item is not returnable. View return policy
This item is not returnable. View return policy

Measure specifc IgE antibodies using ImmunoCAP™ allergens, an essential tool to aid in the diagnosis of allergic conditions.

Quantify specific IgE antibodies with ImmunoCAP™ Tree Pollen Allergens, essential tools to aid in the diagnosis of allergic conditions. IgE antibodies appear in human serum and plasma as a result of sensitization to a specific allergen. Measurement of circulating IgE antibodies provides an objective assessment of sensitization to an allergen. In general, low IgE antibody levels indicate a low probability of allergic disease, whereas high antibody levels to an allergen show a higher correlation with an allergic disease.

ImmunoCAP Specific IgE offers the laboratory:
  • Truly quantitative measuring range from 0.1 to 100 kUA/L
  • Intra-assay CV (%) comparable to routine clinical chemistry immunoassays
  • Excellent consistency over time, and between countries, systems, labs and persons
Expected test values
ImmunoCAP Specific IgE detects IgE antibodies in the range 0.1 to 100 kUA /l, where A represents allergen-specific antibodies. The result is reported quantitatively. In clinical practice, 0.35 kUA /l has commonly been used as a cut-off. A large number of studies have been performed to evaluate the clinical performance of ImmunoCAP Specific IgE tests in allergy diagnosis. Clinical performance is expressed as sensitivity, ranging from 84 to 95%, and specificity, ranging from 85 to 94%. Sensitivity and specificity were reported from multi-center studies including several hundred patients tested for a range of different allergens.
  • Specimen collection and preparation
  • Use serum and plasma (EDTA or heparin) samples from venous or capillary blood
  • Collect blood samples using standard procedures
  • Keep specimens at room temperature (RT) for shipping purposes only
  • Store at 2–8°C up to one week, otherwise store at –20°C
  • Avoid repeated freezing and thawing

Note: Blood samples for testing ImmunoCAP drugs and venom should be collected during or close to the event, preferably not later than 6 months after exposure. If the test result is negative and an IgE-mediated reaction is still strongly suspected, it is advisable to draw a new sample and repeat the test at 5 to 6 weeks.

The presence of specific IgE antibodies is useful to identify the allergens that elicit symptoms and signs of allergy in patients with respiratory allergic diseases including asthma, food allergy, and anaphylactic sensitivity.

Knowing IgE antibody levels provides guidance to clinicians to:
  • Identify offending allergens
  • Tailor advice to individual patients
  • Indicate development of tolerance (food allergy, specific immunotherapy)
  • Inform optimized individual medical treatment plans
  • Refer to specialists appropriately
  • Evaluate whether or not specific immunotherapy is an option

Specific IgE testing also aids in the identification of patients at risk of:
  • The allergy march – a progression of skin symptoms to respiratory symptoms
  • Severe symptoms including asthma exacerbations – a progression of mild symptoms to severe symptoms
  • Progression of recurrent symptoms to persistent symptoms

As in all diagnostic testing, a definitive clinical diagnosis should be made by the clinician after evaluation of all clinical and laboratory findings.
TRUSTED_SUSTAINABILITY

Specifications

Scientific Name Ulmus americana
Regulatory Status FDA Cleared
Code Type Tree
Common Name Elm
Quantity 16 Tests
Code t8
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.